Long-awaited diet pill gets U.S. approval
Sep-11-2014

A new diet pill Contrave got approval to be sold in the United States on Wednesday, only the third obesity treatment in more than a decade to win approval from the Food and Drug Administration.

Made by Orexigen Therapeutics Inc, Contrave is a combination of the antidepressant bupropion and Orexigen's formulation of naltrexone, designed to prevent drug dependence.

The company did not say when the pill would become available or how much it would cost.

The FDA in June had delayed its decision on the drug by three months due to concerns about adequate warnings on the packaging.

Because Contrave contains an antidepressant, it will carry a warning about increased risk of suicidal thoughts and behaviors.

Click the link below for the rest of the article!

Visit Website

Posted by Ken at 1:43 AM - Link to this entry  |  Share this entry  |  Print